© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Fortrea Holdings Inc. (FTRE) stock surged +0.91%, trading at $10.14 on NASDAQ, up from the previous close of $10.05. The stock opened at $10.03, fluctuating between $10.00 and $10.37 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 14, 2026 | 9.47 | 9.71 | 9.46 | 9.59 | 600.26K |
| Apr 13, 2026 | 9.07 | 9.56 | 8.94 | 9.38 | 676.9K |
| Apr 10, 2026 | 9.38 | 9.51 | 8.94 | 9.18 | 583.9K |
| Apr 09, 2026 | 9.46 | 9.59 | 9.09 | 9.38 | 736.79K |
| Apr 08, 2026 | 10.02 | 10.39 | 9.35 | 9.63 | 1.13M |
| Apr 07, 2026 | 8.82 | 9.57 | 8.80 | 9.51 | 1.03M |
| Apr 06, 2026 | 9.42 | 9.48 | 8.55 | 9.01 | 1.2M |
| Apr 02, 2026 | 9.02 | 9.83 | 8.90 | 9.45 | 845.54K |
| Apr 01, 2026 | 9.40 | 9.77 | 9.24 | 9.51 | 999.56K |
| Mar 31, 2026 | 9.10 | 9.68 | 8.86 | 9.42 | 1.32M |
| Mar 30, 2026 | 8.93 | 9.25 | 8.64 | 8.87 | 1.14M |
| Mar 27, 2026 | 9.41 | 9.49 | 8.98 | 9.07 | 791K |
| Mar 25, 2026 | 9.75 | 9.92 | 9.29 | 9.44 | 889.7K |
| Mar 24, 2026 | 9.70 | 9.81 | 9.54 | 9.58 | 692.83K |
| Mar 23, 2026 | 9.68 | 10.09 | 9.46 | 9.75 | 1.02M |
| Mar 20, 2026 | 9.79 | 9.97 | 9.32 | 9.53 | 2.34M |
| Mar 19, 2026 | 9.72 | 10.08 | 9.58 | 9.79 | 1.12M |
| Mar 18, 2026 | 9.46 | 10.16 | 9.32 | 9.94 | 1.64M |
| Mar 17, 2026 | 9.32 | 9.93 | 9.27 | 9.70 | 1.88M |
| Mar 16, 2026 | 9.20 | 9.45 | 8.89 | 9.27 | 1.48M |
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
| Employees | 15000 |
| Beta | 1.78 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | 0.097% |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |